PharmaCyte Biotech Inc (PMCB)

[bulldurham]

I would think that if people read and comprehended today's PR they already KNOW that PharmaCyte Biotech is doing their own studies...

"Each of the preclinical studies in ascites are being conducted by Translational Drug Development (TD2) - the premier CRO in the United States specializing in oncology. TD2 is also the CRO conducting PharmaCyte’s upcoming clinical trial in advanced pancreatic cancer."

'PharmaCyte’s initial series of preclinical studies were done with mice that had been inoculated with a human ovarian cancer.'

'The data obtained from these studies provided information that is being used as a foundation for future studies on other tumor types.'

'The results from this initial series of studies are now being used in connection with new colon cancer studies that may prove to be effective in developing a treatment that delays the production of malignant ascites fluid in cancer patients.'

'In part because colon cancer is the most commonly diagnosed cancer of the digestive tract, a new preclinical study has just begun in mice that have been inoculated with the regularly used Colon 26 mouse model.'


bull